A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
A new study shows that an ancient mechanism of regulating a cell’s protein repertoire allows malaria parasites to hide from fast-acting artemisinin drugs and survive.
Initial reports of the bivalent booster’s effectiveness have created confusion among the public. David Ho discusses his own results, the bottom line, and what to expect from COVID this winter.
Cases of COVID, influenza, and RSV are surging in children and adults, along with a slew of other infectious diseases that went under the radar during the first two years of the pandemic.
More than 90% of Americans have been immunized against polio, but the news is still unsettling and has many wondering if they’re at risk of becoming infected or even paralyzed.
Three infectious disease experts at Columbia University Irving Medical Center presented the latest updates on monkeypox at a briefing Aug. 16 for CUIMC faculty, staff, and students.
The monkeypox has recently been declared a public health emergency in the United States and experts have expressed concern that the virus could become endemic.
The latest omicron subvariants—especially the currently dominant BA.4 and BA.5 forms—are even better at eluding vaccines and most treatments, find researchers at Columbia University.
Community outreach and restricting online scheduling to certain zip codes helped increase vaccine uptake among Black and Hispanic residents, new study says.
Columbia scientists have joined a regional consortium to accelerate the development of new drugs that target SARS-CoV-2, other coronaviruses, and viruses that could lead to future pandemics.